Announcing the 2018 AZBio Trailblazers

The 2018 AZBio Trailblazer Honorees are: Senator Nancy Barto, Senator Sean Bowie, Senator Kate Brophy McGee, Representative Douglass Coleman, Representative Heather Carter, Representative Regina Cobb, DDS, Representative Randall Friese, MD, Representative Mark Finchem, Representative Maria Syms, and  Representative Jeff Weninger.

Senator Kimberly Yee will be honored with the Chairman’s Award.

Continue reading

Watch the AZBio Award 2016 Keynote Videos

The 2016 AZBio Awards brought together over 500  leaders from across the state of Arizona and around the country.  The Honorable Douglas A. Ducey, Governor of the State of Arizona, opened the program followed by a keynote by Arizona Bioscience Pioneer Award Honoree Dr. George Poste.    Later in the evening, our AZBio Baby danced, a world renowned cellist performed, Joan had a few things to say, and the audience celebrated with our 2016 AZBio Award honorees.  (Click here to see the videos on our 2016 AZBio Awards Winners.)

Continue reading

Leaders from ASU and Mayo to share insights on Cancer Research at Free Virtual Conference in October

Dr. Anna Barker and Dr. George Poste of ASU and Dr. Donald Tindall and Dr. Allan Jaffe of Mayo to share insights at BioConference Live’s Ground-Breaking Cancer Research, Discovery and Therapeutics FREE Virtual Conference in October.

First of Its Kind Online-Only Conference Focusing on Cancer with Live Streaming Video Presentations Delivered by Industry Experts; Earn Continuing Medical Education CreditsContinue reading

Opportunity Alert: Submit Your Ideas for Session Presentations at BIO 2014

bio 2014 sessions

The Call for Sessions opens September 5th for the

BIO International Convention

in San Diego, June 23-26, 2014.

Education enhancements in 2014 include: streamlined session tracks organized by role in the industry and featuring international representation among panels; specialty forums with cohesive content and targeted networking receptions.


Start planning today: session proposals will be accepted Thursday, September 5 through Thursday, October 3, 2013.

How to develop our suggestion:

  • Review the list of tracks and topic area suggestions to determine which topics are relevant and pressing
  • Talk with colleagues and industry contacts about your idea; brainstorm potential speakers
  • Use the Session Proposal Guide for step-by-step tips to maneuver the online submission process

Please note, proposals for the International Market Briefings (IMB) Track will be accepted separately October 14 – November 4, 2013.

With the 2014 BIO International Convention being held in San Diego, this is a great opportunity to show the world what Arizona has to offer.

QUESTIONS?  If you have any questions about your topic, how to submit, etc. Email BIO at

Visit for more information.



12th Annual BIO Investor Forum in October


Announcing the 12th Annual BIO Investor Forum

The Biotechnology Industry Organization (BIO) is pleased to announce its advisory committee for the 12th Annual BIO Investor Forum, an international biotech investor conference focused on investment strategies for early stage and established private companies as well as emerging public companies. The event will take place October 8-9, 2013 at the Palace Hotel in San Francisco, Calif.

This esteemed group will help set the agenda and program for this year’s event which will assemble public and venture-stage growth companies, as well as top public and private equity investors, to explore investment trends and opportunities in life sciences.

Advisory Committee members include:

  • Srini Akkaraju, MD, PhD, General Partner, Sofinnova Venture
  • Katrine Bosley, (former) CEO, Avila Therapeutics
  • Ashley Dombkowski, CBO, 23andMe
  • Todd Foley, Managing Director, MPM Capital
  • Gail Maderis, President & CEO, BayBio
  • Janis Naeve, PhD, Managing Director, Amgen Ventures
  • Bryan Roberts, PhD, Partner, Venrock
  • Eugene Rozelman, Managing Director, Canaccord Genuity
  • Francesco De Rubertis, PhD, Partner, Index Ventures
  • Geeta Vemuri, PhD, VP, Head, Baxter Ventures
  • Barbara Yanni, Vice President & Chief Licensing Officer, Merck
  • Krishna Yeshwant, Partner, Google Ventures

In addition to panel discussions led by clinical thought leaders focusing on hot therapeutic areas, the conference features business roundtables focused on financing, investment and the latest M&A trends. BIO One-on-One Partneringwill also provide an opportunity to arrange meetings between investors; companies; and industry business development, licensing and therapeutic franchise heads.


The BIO Investor Forum has become the ideal venue for investors and business development leaders to discuss financial and strategic business issues affecting investment in biotech companies, and explore potential partnerships and business collaborations to fuel research and development for promising innovation. Last year’s conference scheduled over 650 meetings. Nearly 80% of all requests were between biotech companies and investors.  Furthermore, the event hosted nearly 110 late-stage private and emerging public company presentations.

The meeting attracts healthcare venture capital and public market investors and research analysts as well as business development executives from leading global pharmaceutical and biotechnology companies.

For more information, please go to

BIO Investor Forum Features

  • BIO 1×1 Meetings
  • Plenary Sessions and Workshops
  • Company Presentations
  • Networking Opportunities

Venue Information

The Palace Hotel

2 New Montgomery Street
San Francisco, CA 94105


What will the BIO Investor Forum mean to your company?Contact Us


Customer Service:

1.866.356.5155 (U.S.) or
+1.202.962.6666 (International)

Sponsorship Opportunities:

John Sloan, Managing Director,
External Relations & Development, BIO